David R. Pelizzon - 10 Sep 2026 Form 4 Insider Report for ORTHOPEDIATRICS CORP (KIDS)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: KIDS
Reported as of: 10 Sep 2026
Net transaction value: -$6,352,773
SEC form: 4
Accepted by SEC: 10 Sep 2026, 16:21:14 UTC
Prior SEC filing: 04 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Daniel J. Gerritzen, Attorney-in-Fact

Key filing fact

David R. Pelizzon filed Form 4 for ORTHOPEDIATRICS CORP (KIDS) on 10 Sep 2026.

Key facts

This page summarizes David R. Pelizzon's Form 4 filing for ORTHOPEDIATRICS CORP (KIDS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Sep 2026, 16:21.

Change

Previous filing in this sequence was filed on 04 Sep 2026.
Current net transaction value: -$6,352,773.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001719217 Primary reporting owner

Pelizzon David R

Relationship: Director, 10%+ Owner
Address: C/O SQUADRON CAPITAL LLC, 18 HARTFORD AVE., PO BOX 223, GRANBY
Signature: /s/ Daniel J. Gerritzen, Attorney-in-Fact
Signature date: 10 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KIDS transaction

Common Stock

Sale

Transaction value: $6,352,773
Shares: -302,369
Change %: -4.6%
Price: $21.01
Shares after: 6,201,764
Date: 10 Sep 2026
Ownership: See footnote
Footnotes: F1, F2, F3

KIDS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 44,384
Date: 10 Sep 2026
Ownership: Direct
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Footnote F3

These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Footnote F4

Includes restricted stock awards totaling 17,959 shares.